All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @alphaclubsupps on TikTok · 73s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @alphaclubsupps's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Is high hermitic rate on TRT dangerous? You see a lot of guys get their blood work back and they
  2. 0:04see that that number is in the red and they start to fucking panic. But the truth is a little bit
  3. 0:09more nuanced than that. And hermitic rate is the percentage of your blood that's made up of red
  4. 0:12blood cells. More red blood cells means thicker blood. When using testosterone this almost always
  5. 0:18raises that number. A usual healthy range is about 40 to 50 percent and most labs are going to
  6. 0:23flag you if it gets over 52. But guys who are on cycles quite often run 54, 55 percent. So if
  7. 0:29you get your bloods back and you'll run in that number high don't fucking panic. There's no need
  8. 0:34just to run out and book yourself a blood donation straight away. And that's not to say there's no
  9. 0:38risk involved at all. That's why we look at these markers. So if you have a history of high blood
  10. 0:43pressure, if you've got underlying health issues that evolve around blood clotting or if you're a heavy
  11. 0:49smoker then you've got to take it more into consideration. But if you're fit and healthy and you stay
  12. 0:55well hydrated each day and you're super active it's not so much to worry about at those higher
  13. 1:00levels. Don't just crash your dose and throw the baby out with the bath water and crash all the
  14. 1:04good work you've already done. So do yourself some research and as always do yourself a favor
  15. 1:09drop me a follow. Bush.

TRT and high hematocrit: is thick blood actually dangerous?

Alpha Club Supplements UK

TikTok creator

10.5K viewsWatch on TikTok

Quick answer

Testosterone therapy reliably stimulates erythropoiesis, raising hematocrit in a significant proportion of users, with rates of erythrocytosis above 54% reported in roughly 3-18% of TRT patients depending on formulation and dose (Bhasin et al., 2018, JCEM). Current Endocrine Society guidelines recommend withholding TRT when hematocrit exceeds 54% until levels normalize, and therapeutic phlebotomy is a guideline-supported intervention, not an overcautious one. The risk profile does vary with individual cardiovascular and clotting history, but blanket reassurance without clinical context is not consistent with standard monitoring practice.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 5 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For TRT and high hematocrit: is thick blood actually dangerous?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

TRT and high hematocrit: is thick blood actually dangerous? is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "TRT and high hematocrit: is thick blood actually dangerous?" from Alpha Club Supplements UK. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Testosterone therapy reliably stimulates erythropoiesis, raising hematocrit in a significant proportion of users, with rates of erythrocytosis above 54% reported in roughly 3-18% of TRT patients depending on formulation and dose (Bhasin et al.

The reason this review is not generic is the source wording and the canonical claim label "trt high hematocrit freaks guys out on trt but should it it just." In this clip, the useful excerpt is: "Is high hermitic rate on TRT dangerous?" That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Therapeutic phlebotomy is a standard, guideline-supported intervention for TRT-induced erythrocytosis.
People who land here are usually trying to understand whether the Testosterone claim is evidence-backed, safe, and relevant to their own situation.
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Testosterone therapy reliably stimulates erythropoiesis, raising hematocrit in a significant proportion of users, with rates of erythrocytosis above 54% reported in roughly 3-18% of TRT patients depending on formulation and dose (Bhasin et al.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Testosterone therapy reliably stimulates erythropoiesis, raising hematocrit in a significant proportion of users, with rates of erythrocytosis above 54% reported in roughly 3-18% of TRT patients depending on formulation and dose (Bhasin et al., 2018, JCEM). Current Endocrine Society guidelines recommend withholding TRT when hematocrit exceeds 54% until levels normalize, and therapeutic phlebotomy is a guideline-supported intervention, not an overcautious one. The risk profile does vary with individual cardiovascular and clotting history, but blanket reassurance without clinical context is not consistent with standard monitoring practice.
  • Endocrine Society guidelines (Bhasin et al., 2018, JCEM) recommend withholding TRT when hematocrit exceeds 54%, pending clinical evaluation. That threshold is not arbitrary.
  • Therapeutic phlebotomy is a standard, guideline-supported intervention for TRT-induced erythrocytosis. Being told not to consider it is not neutral advice.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Endocrine Society guidelines (Bhasin et al., 2018, JCEM) recommend withholding TRT when hematocrit exceeds 54%, pending clinical evaluation. That threshold is not arbitrary.
  • Therapeutic phlebotomy is a standard, guideline-supported intervention for TRT-induced erythrocytosis. Being told not to consider it is not neutral advice.
  • The TRAVERSE trial (Lincoff et al., 2023, NEJM) found no significant increase in major cardiovascular events with TRT, but participants were monitored. Unmanaged erythrocytosis was not part of that finding.
  • Blood viscosity increases sharply above 52-54% hematocrit, raising shear stress and thrombotic risk. Staying hydrated is supportive but does not correct the underlying erythrocytosis (Baskurt and Meiselman, 2003, Seminars in Thrombosis and Hemostasis).
  • Injection-based testosterone tends to produce larger hematocrit spikes than gels or patches due to peak-and-trough pharmacokinetics. Delivery method matters and is a clinical lever worth discussing with a provider.
  • The fact that elevated hematocrit is common among unsupervised users is not evidence that it is safe. Prevalence and safety are different things.
  • If your hematocrit is flagged on TRT labs, the right move is to discuss it with a clinician, not to self-assess your fitness level and move on.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @alphaclubsupps actually say?

The creator's core argument is that high hematocrit on TRT is overblown. He says guys "panic" when they see elevated numbers, but that for fit, active, well-hydrated men, running at 54-55% is "not so much to worry about." He also explicitly tells viewers not to rush to donate blood or reduce their dose.

To be fair, he does carve out exceptions: guys with high blood pressure, clotting disorders, or heavy smokers should "take it more into consideration." That's a real caveat. But the overall tone is dismissive, and that's where the problem starts. Telling a general audience not to panic and not to donate blood, without knowing their cardiovascular baseline, goes further than the evidence supports.

Does the science back this up?

Partially, but the reassuring framing is doing a lot of heavy lifting here. The risks of elevated hematocrit are real and dose-dependent, and they do not disappear just because someone is active and hydrated.

A 2018 meta-analysis by Corona et al. in Sexual Medicine Reviews found that testosterone therapy was associated with increased hematocrit, and that erythrocytosis (typically defined as hematocrit above 54%) was one of the most common adverse effects of TRT. More critically, a 2023 cardiovascular outcomes trial, the TRAVERSE study (Lincoff et al., New England Journal of Medicine), found that testosterone therapy did not significantly increase major adverse cardiovascular events overall, but the study population was monitored and managed. That is not the same as saying unmanaged erythrocytosis is safe.

The hematocrit-viscosity relationship is not linear. Blood viscosity rises sharply above 52-54%, increasing shear stress on vessel walls and raising thrombotic risk. Baskurt and Meiselman (2003, Seminars in Thrombosis and Hemostasis) documented this relationship clearly. Hydration helps, but it does not normalize viscosity at clinically elevated hematocrit levels. The "just stay hydrated" advice understates what is actually happening physiologically.

What did they get wrong (or right)?

He got the basic definition right. Hematocrit is the percentage of blood volume made up of red blood cells, and testosterone does reliably raise it. The normal reference range of 40-50% and the 52% flag threshold are accurate for most standard labs.

Where he goes wrong is the blanket reassurance. Telling viewers not to "run out and book a blood donation straight away" could actively delay a reasonable, clinician-recommended intervention. Therapeutic phlebotomy is a standard and well-supported management strategy for TRT-induced erythrocytosis, recommended in guidelines from the Endocrine Society (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism). It is not an overreaction.

He also implies that "guys on cycles" routinely running 54-55% sets some kind of precedent for safety. It does not. The fact that something is common among a population that often avoids medical supervision is not evidence that it is safe. That is a normalization argument, not a clinical one.

Credit where it is due: he correctly identifies that the risk picture changes with comorbidities. That nuance is accurate and worth saying.

What should you actually know?

Hematocrit above 52% on TRT should prompt a conversation with whoever is managing your care, not a solo decision about whether to panic or not. The Endocrine Society guidelines recommend against initiating or continuing TRT when hematocrit exceeds 54%, pending evaluation. That threshold exists for a reason.

Therapeutic phlebotomy, dose adjustment, or switching delivery method (injections tend to cause larger spikes than gels due to peak-and-trough pharmacokinetics) are all legitimate options that a clinician can help you weigh. Staying hydrated is sensible but it is supportive, not corrective.

If you are on a TRT protocol through a supervised platform, elevated hematocrit is exactly the kind of marker that should be reviewed before you decide it is nothing. The creator is right that not every elevated number is an emergency. He is wrong to suggest that doing research yourself and not donating blood is a reasonable substitute for medical guidance at those levels.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Alpha Club Supplements UK · TikTok creator

10.5K views on this video

High hematocrit freaks guys out on TRT… but should it? 🩸 It just means your blood is carrying more red cells. That’s why labs flag it when it creeps past 52%. Yes, thick blood can raise risk if you’ve got blood pressure issues, clotting problems, or you smoke. But for most guys on TRT, it’s not an instant crisis. The key is simple: monitor it, stay hydrated, and don’t overreact. Panic doesn’t fix numbers — smart management does. 💉

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about endocrine society guidelines (bhasin et al., 2018, jcem) recommend withholding?

Endocrine Society guidelines (Bhasin et al., 2018, JCEM) recommend withholding TRT when hematocrit exceeds 54%, pending clinical evaluation. That threshold is not arbitrary.

What does the video say about therapeutic phlebotomy?

Therapeutic phlebotomy is a standard, guideline-supported intervention for TRT-induced erythrocytosis. Being told not to consider it is not neutral advice.

What does the video say about the traverse trial (lincoff et al., 2023, nejm) found no?

The TRAVERSE trial (Lincoff et al., 2023, NEJM) found no significant increase in major cardiovascular events with TRT, but participants were monitored. Unmanaged erythrocytosis was not part of that finding.

What does the video say about blood viscosity increases sharply above 52-54% hematocrit, raising shear stress?

Blood viscosity increases sharply above 52-54% hematocrit, raising shear stress and thrombotic risk. Staying hydrated is supportive but does not correct the underlying erythrocytosis (Baskurt and Meiselman, 2003, Seminars in Thrombosis and Hemostasis).

What does the video say about injection-based testosterone tends to produce larger hematocrit spikes than gels?

Injection-based testosterone tends to produce larger hematocrit spikes than gels or patches due to peak-and-trough pharmacokinetics. Delivery method matters and is a clinical lever worth discussing with a provider.

What does the video say about the fact?

The fact that elevated hematocrit is common among unsupervised users is not evidence that it is safe. Prevalence and safety are different things.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Alpha Club Supplements UK, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.